Literature DB >> 11322650

Different mechanisms in inhibition of rat macrophage nitric oxide synthase expression by FK 506 and cyclosporin A.

P Strestíková1, B Otová, M Filipec, K Masek, H Farghali.   

Abstract

The modulatory effect of FK 506 and cyclosporin A (CsA) on the expression of inducible nitric oxide synthase (iNOS) in macrophages and mechanisms of their action were analysed. Isolated rat peritoneal macrophages were cultured for 12 or 24 h with or without lipopolysaccharide (LPS) (5 microg/ml) and in the absence or presence of FK 506 or CsA (0.1 and 1 microg/ml). Total RNA from macrophages was isolated and the expression of the gene for iNOS was assessed by using RT-PCR. The concentration of NO2- in culture supernatants was taken as a measure of nitric oxide (NO) production. FK 506 (0.1 and 1 microg/ml) reduced the LPS-induced increase of NO2- levels by 68% and 81%, respectively. CsA (0.1 and 1 microg/ml) decreased levels of nitrites by 39% and 69%, respectively. The results obtained suggest that both immunosuppressive drugs exhibit dose-dependent inhibitory effect on NO production and that FK 506 is more potent agent than CsA, in this respect. FK 506 exhibits its inhibitory effect on a phosphatase at the transcriptional level in macrophages. iNOS expression down-regulation by CsA is occurred post-transcriptionally.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11322650     DOI: 10.1081/iph-100102568

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  3 in total

1.  Intravitreal injection of Tacrolimus (FK506) suppresses ongoing experimental autoimmune uveoretinitis in Rats.

Authors:  Keiko Oh-i; Hiroshi Keino; Hiroshi Goto; Naoyuki Yamakawa; Kouhei Murase; Yoshihiko Usui; Takeshi Kezuka; Jun-Ichi Sakai; Masaru Takeuchi; Masahiko Usui
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

2.  Early steps of microglial activation are directly affected by neuroprotectant FK506 in both in vitro inflammation and in rat model of stroke.

Authors:  Malgorzata Zawadzka; Michal Dabrowski; Agata Gozdz; Barbara Szadujkis; Marcin Sliwa; Maciej Lipko; Bozena Kaminska
Journal:  J Mol Med (Berl)       Date:  2012-07-18       Impact factor: 4.599

3.  Methotrexate and cyclosporine treatments modify the activities of dipeptidyl peptidase IV and prolyl oligopeptidase in murine macrophages.

Authors:  R A Olivo; N G Nascimento; C F P Teixeira; P F Silveira
Journal:  Clin Dev Immunol       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.